Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Another Setback for Roche's Cancer Drug
Seeking Alpha
Sunday, September 26, 2010 - 12:47pm
tags:
Roche, Avastin, colon cancer
Private Biotechs Take Different Avenues to Rake in Cash
Seeking Alpha
Sunday, September 26, 2010 - 12:45pm
tags:
Reata, Abbott Laboratories, Bardoxolone, chronic kidney disease, Asthmatx, Boston Scientific, CytomX, Emergent BioSolutions
GSK's Diabetes Pill: Lessons Learned, Unanswered Questions
Seeking Alpha
Sunday, September 26, 2010 - 12:28pm
tags:
GSK, Avandia, diabetes
$93,000 cancer drug: How much is a life worth?
Yahoo/AP
Sunday, September 26, 2010 - 12:27pm
tags:
Provenge, Dendreon, Revlimid, Celgene
A Busy Week for Multiple Sclerosis News
Seeking Alpha
Sunday, September 26, 2010 - 12:24pm
tags:
Novartis, Merck KGaA, Gilenya, multiple sclerosis, cladribine, Biogen Idec, Bayer, Teva Pharmaceuticals
Will the FDA Give Vivus More Time Before the Final Judgment on Qnexa?
Seeking Alpha
Sunday, September 26, 2010 - 12:22pm
tags:
Qnexa, Vivus, obesity
Diabetes Therapeutic Market Reached $24.9 Billion in 2009
PR-USA.net
Saturday, September 25, 2010 - 1:13pm
tags:
diabetes
Merck considers appeal of MS drug rejection
Financial Times, UK
Saturday, September 25, 2010 - 1:11pm
tags:
Merck, multiple sclerosis, cladribine
Lundbeck Launches New Research And Development Strategy
Medical News Today
Saturday, September 25, 2010 - 1:09pm
tags:
Lundbeck
Eli Lilly and Company Encourages African-Americans to Get a Check-up and Face Diabetes
Trading Markets
Saturday, September 25, 2010 - 1:07pm
tags:
Eli Lilly, diabetes
Dynavax Technologies Corp commences Phase 1b trial for Universal Flu Vaccine
Trading Markets
Saturday, September 25, 2010 - 1:05pm
tags:
Dynavax, flu vaccine, vaccines
Prepare for This $12 Billion Whoosh (Lipitor Generic)
Motley Fool
Saturday, September 25, 2010 - 12:16pm
tags:
Pfizer, Lipitor, AstraZeneca, Crestor, Merck, Zocor
Priority Review for AZN Drug
Yahoo/Zacks
Saturday, September 25, 2010 - 12:14pm
tags:
AstraZeneca, vandetanib, thyroid cancer
AstraZeneca, Bristol Myers Move Forward With Diabetes Drug
Minyanville
Saturday, September 25, 2010 - 12:11pm
tags:
AstraZeneca, Bristol-Myers Squibb, Dapagliflozin, diabetes
Harwood Feffer LLP Files Class Action On Behalf Of Purchasers Of XenoPort, Inc. Securities For The Enlarged Class Period March 16, 2009 Through February 17, 2010
Yahoo/BusinessWire
Saturday, September 25, 2010 - 12:09pm
tags:
XenoPort
J&J Expands Options For Prostate Cancer
Yahoo/Investor's Business Daily
Saturday, September 25, 2010 - 12:08pm
tags:
JNJ, prostate cancer, abiraterone, Provenge, Dendreon
Vical shares sink as company handles drug failure
Yahoo/AP
Saturday, September 25, 2010 - 12:06pm
tags:
Vical, Sanofi, critical limb ischemia
Advaxis Chairman and CEO Issues Statement to Shareholders
Yahoo/BusinessWire
Saturday, September 25, 2010 - 12:04pm
tags:
Advaxis, cervical dysplasia, cervical cancer, investors
Are Shorts Watching Qiagen?
Motley Fool
Saturday, September 25, 2010 - 12:03pm
tags:
Qiagen, investors
Oncothyreon in $15M private placement; stock dives
bizjournals.com
Saturday, September 25, 2010 - 12:01pm
tags:
Oncothyreon, investors

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.